Salta al contenuto principale
Passa alla visualizzazione normale.


COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients.

  • Autori: The COMEPA group; Barbagallo M.; Citarrella R.; Dominguez L. J.; Giannitrapani L.; Licata A.; Mansueto P.; Soresi M.; Veronese N.
  • Anno di pubblicazione: 2021
  • Tipologia: Articolo in rivista
  • OA Link:


Coronavirus disease 2019 (COVID-19) has dramatically changed our lives. In the past months, hospitals were saturated of patients; therefore, it is still important to have simple and standardized prognostic factors and to evaluate the efficacy and safety of medications commonly used for COVID-19. We aimed to collect data of the patients hospitalized in Internal Medicine and Geriatrics Wards at the University Hospital (Policlinico) ‘P. Giaccone’ in Palermo, Italy (COMEPA, COVID-19 Medicina Policlinico Palermo), with the main purpose of finding prognostic tools that can be easily used in clinical practice in order to identify patients hospitalized for/with COVID-19 at higher risk of negative outcomes, such as mortality, transfer to Intensive Care Unit (ICU) and institutionalization, as well as evaluating the efficacy/safety of medications commonly used for COVID-19. For reaching these aims, the medical records of approximately 600 patients will be recorded, having data on several parameters and including as outcomes mortality, ICU placement, institutionalization. With the COMEPA study, we therefore plan to update current literature, giving new data on prognostic factors and on the efficacy/safety of some medications used for COVID-19.